A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia
Clinical trial NCT00350467 · COMPLETED
Trial details
- NCT number
- NCT00350467
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.